Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
주식 순위 #32325
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
주가
$0.88
마지막 동기화: 2026-08-17
시가총액
$10.41M
변동 (1일)
-7.26%
변동 (1년)
-50.56%
국가
SG
거래 CytoMed Therapeutics Limited (GDTC)

카테고리

CytoMed Therapeutics Limited (GDTC)의 주가 이력
최고 종가: $0.84 (2026-08-01 기준)

최저 종가: $3.48 (2023-04-01 기준)
CytoMed Therapeutics Limited의 주가 이력 (2023 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$515.58 32.24%
US
$992.01 50.00%
NL
$110.14 -37.49%
AU
$736.64 6.99%
CH
$1.06K -7.10%
KR